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Resistance to the “Last Resort” Antibiotic Colistin: A Single-Zinc 
Mechanism for Phosphointermediate Formation in MCR Enzymes 
Emily Lythella,bǂ, Reynier Suardiaza,c,d,e˧ǂ, Philip Hinchliffebǂ, Chonnikan Hanpaiboolf, Surawit 
Visitsatthawongg, A. Sofia F. Oliveiraa,c, Eric J. M. Langa, Panida Surawatanawongg, Vannajan 
Sanghiran Leeh, Thanyada Rungrotmongkulf,i, Natalie Feya, James Spencer*b, Adrian J. 
Mulholland*a
MCR (mobile colistin resistance) enzymes catalyse 
phosphoethanolamine (PEA) addition to bacterial lipid A, 
threatening the “last-resort” antibiotic colistin. Molecular 
dynamics and density functional theory simulations indicate that 
monozinc MCR supports PEA transfer to the Thr285 acceptor, 
positioning MCR as a mono- rather than multinuclear member of 
the alkaline phosphatase superfamily. 
Multidrug-resistant Gram-negative bacteria (GNB, e.g. 
Escherichia coli, Klebsiella pneumoniae), are a serious, growing, 
global public health threat.1 Treatment options are limited by a 
lack of new antimicrobials2 and dissemination of resistance 
plasmids.3 The polymyxin colistin is a ‘last-resort’ antibiotic for 
GNB resistant to preferred agents (cephalosporins, 
carbapenems)4 but is threatened by plasmid-encoded MCR 
(mobile colistin resistance) enzymes.5 MCR expression in GNB 
carrying other resistance determinants (extended-spectrum or 
carbapenem-hydrolysing β-lactamases6), threatens untreatable 
bacterial infections and a return to the pre-antibiotic era. 
 MCR enzymes transfer positively charged phospho-
ethanolamine (PEA) onto the 1’ or 4’ phosphates of lipid A 
(Figure S1) in outer membrane lipopolysaccharide(LPS) of GNB. 
PEA addition decreases lipid A net negative charge, reducing 
affinity for positively charged colistin. PEA transferases such as  
Figure 1: MCR Active Site. Zn1 and Zn2 ligating atoms in dizinc MCR-1 (PDB 
5LRM) are shown. Active site residues are conserved in MCR-1 and -2 (PDBs 
5LRN7, 5LRM7, 6SUT, 5MX98) with catalytic Thr285 phosphorylated in 
monozinc structures (5LRN, 6SUT, see Figure S2). Additional Zn2 coordination 
by Glu300/405 (red) arises from contact with a symmetry related molecule.  
 
MCR-1 are metal-dependent, inner-membrane bound enzymes, 
with a periplasmic catalytic domain and a conserved threonine 
(MCR-1 Thr285), as likely PEA acceptor in the transfer reaction. 
 We recently crystallised the periplasmic domains of MCR-1 
and MCR-2, revealing a conserved active site resembling other 
bacterial PEA transferases and alkaline phosphatase (AP),7, 8 and 
identifying MCR proteins as members of the AP core 
superfamily. Our structures have either one (mono-) or two 
(dizinc) active site zinc ions; further structures crystallised under 
higher (non-physiological) zinc concentrations feature active 
sites with up to 5 zinc ions.9, 10 A full-length homologue 
(Neisseria meningitidis EptA, 36% identical to MCR-2) contains 
a single zinc ion.11 Only one zinc site (Zn1), tetrahedrally 
coordinated by MCR Glu246, His466, Asp465 and Thr285 (Figure 
1; Table S1) is conserved in all PEA transferase structures.7 
 Where present the second (Zn2) site is coordinated by 
residues His395 and His478, a water molecule, and Glu300 or 
Glu405 from a crystal contact with an adjacent chain (Figure 1, 
PDB 5LRM).7 although the MCR-17 and -28 catalytic domains 
exist as monomers in solution. Furthermore, in most (8/11) 
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MCR-1 and -2 structures the catalytic Thr285 is phosphorylated, 
possibly representing the binding mode of phospho-linked PEA 
substrates. In phosphorylated structures, most of which contain 
a single zinc ion, the Zn2-binding His395 forms a weak (~3.1 Å) 
hydrogen bond to phosphoThr285. Mutation to alanine of any 
Zn1-coordinating residues, or of His395, completely abolishes 
MCR-1/-2 activity, as measured by colistin susceptibility of 
MCR-expressing E. coli.12 However, mutation of the Zn2-
coordinating His478 reduced but did not abolish activity,7 
indicating this residue as important, but not essential, to activity 
and challenging the essentiality of an intact Zn2 site. 
 The mechanism of MCR-catalysed PEA transfer to lipid A is 
currently unknown. Resemblance to AP has motivated 
proposals of similar mechanisms,9 although current models for 
AP catalysis involve two or three zinc ions.13-16 Importantly, 
however, the AP superfamily also contains monometallic 
enzymes (e.g. phosphonate monoester hydrolase, PMH), where 
basic amino acids functionally substitute for additional metal 
ions to orient substrate for nucleophilic attack, stabilise the 
transition state and activate incoming water to degrade the 
covalent phospho-intermediate.17-19 Key questions in 
understanding MCR enzymes then concern the number of metal 
ions required for the two reaction steps (PEA transfer to MCR 
Thr285 and subsequently to lipid A). Here we combine X-ray 
crystallography, molecular dynamics (MD) simulations and DFT 
calculations to investigate the structure, stability, dynamics and 
PEA transfer activity of the MCR metal centre.20 
 Crystal structures of MCR-1 and -2 in both phosphorylated 
(monozinc, PDB 5LRN7, 6SUT (this work, Figure S2, Table S2)) 
and dephosphorylated (dizinc, PDB 5LRM7, 5MX98) states were 
used as starting points for molecular dynamics (MD) simulations 
of ≥ 200 ns. These confirmed the isolated catalytic domain as a 
rigid, stable entity, supporting its use as a model system for 
computational investigations of MCR dynamics/mechanism 
(Figures S3, S4). Interestingly, residues 348 – 365 show similar 
mobility to other solvent-exposed regions, inconsistent with 
previous proposals implicating this loop in substrate binding21. 
 We next analysed the dynamic behaviour of Zn1 and Zn2 in 
MD simulations of mono- and bi-metallic MCR-1/-2, modelling 
the metal ions with a nonbonded Lennard-Jones 12-6 approach 
with restraints during minimisation, heating, and equilibration. 
This represents a compromise between preventing repulsion 
between metal ions in multinuclear systems and allowing for 
ligand exchange (not possible in fully bonded/dummy atom 
approaches) and evaluation of stability of different metallated 
states. In 3/5 200 - 300 ns simulations of dizinc MCR-1, and 2/3 
simulations of dizinc MCR-2, zinc dissociated from the Zn2 site 
(His395/His478, Figure 2). Even when complete dissociation 
was not observed, the Zn2 RMSF (MCR-1 9.9 Å, MCR-2 4.9 Å) 
was consistently higher than for Zn1 (MCR-1 5.0 Å, MCR-2 3.1 
Å), confirming the Zn1 site as significantly more stable than Zn2 
with a likely much lower dissociation constant. Coordination 
distances (Figure S5) indicate only minor perturbation of the 
Zn1 site upon loss of Zn2. Consistent with biochemical data22 
and the N. meningitidis EptA structure11, these data identify 
only one stable zinc site (Zn1) in the MCR catalytic domain. 
 Coordination geometry at the Zn1 site was then considered.  
Figure 2: Dissociation of Zn2 from Unphosphorylated MCR-1. Zn2 (labelled) 
dissociates from MCR-1 (PDB 5LRM) after 161 ns of a 300 ns MD 
trajectory. Figure shows 7 snapshots spanning 161 to 161.7 ns of the 
trajectory, with Zn2 ion positions coloured by frame from blue (161 ns) 
to deep red (161.7 ns). 
 
During MD simulations of both mono- and dizinc MCR-1/-2 the 
Zn1-coordinating residues Glu246, Asp465, His466 and Thr285 
show significant sidechain flexibility. In monozinc MCR-1/-2, 
each adopts multiple distinct conformations (Figure S6); His466 
moves away from the zinc ion and both carboxylate ligands 
(Glu246, Asp465) adopt either mono- or bidentate coordination 
(Figure S7, Table S3), but with minimal preference between 
rotamers. In simulations of the dizinc enzymes Glu246 favours 
mono- over bidentate Zn1 coordination, despite potential loss 
of a stabilising “second shell” interaction with His395, which 
instead coordinates Zn2. Monodentate Zn1 coordination by 
Glu246 is more consistent with crystal structures of both mono- 
and dizinc MCR-1/-2.7, 8 While, at this level of sampling, 
conclusions drawn from relative rotamer preferences may be 
limited, these simulations both replicate crystallographically 
observed zinc coordination and identify active site flexibility 
(Asp465 and Glu246 in exchange between mono- and bidentate 
coordination) that may be mechanistically relevant. 
 MCR is expected to catalyse PEA transfer via a covalent, 
Thr285-bound phospho-intermediate, thus it is also relevant to 
consider how modification of Thr285 (that in unphosphorylated 
MCR enzymes coordinates Zn1) affects the active site. During 
simulations of dizinc MCR-1/-2 Thr285 O maintains contact 
with Zn1 before and after Zn2 dissociation, indicating that 
unphosphorylated Thr285 stably coordinates Zn1 regardless of 
occupation of the Zn2 site. As above, Zn1 remains bound in the 
active site throughout, flexibly coordinated by Asp465 and 
Glu246 (Figure S8). Thus Thr285 dephosphorylation in monozinc 
MCR-1/-2 has limited effect on Zn1 architecture and dynamics. 
 Thr285 is consistently observed phosphorylated in crystal 
structures of monozinc MCR-1/-2, making possible additional 
interactions, that persist throughout MD simulations, of Zn1 
with the more strongly charged terminal phosphate oxygen 
atom. As crystal structures of dizinc phosphorylated MCR-1/-2 
remain unavailable, an additional model was created to probe 
the effect of Thr285 phosphorylation on stability of the Zn2 site. 
In MD simulations zinc remains stably bound in the Zn1 site 
after in silico phosphorylation of dizinc MCR-1/-2, with Glu246 
and Asp465 in exchange between mono- and bidentate 
coordination, but coordination by His466 is lost and 
phosphoThr285 moves closer towards the Zn2 site and 
becomes more solvent-exposed. As expected, the proximity of 
the negatively-charged Thr285 phosphate group invariably  
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 Figure 3: Favoured Reaction Path for Phosphoethanolamine (PEA) addition to MCR-1/2 Thr285. Figure shows reactant (RS), transition (TS) and product (PS) 
states for pathway A (favoured; pathway B shown in Figure S11), derived from DFT models for PEA transfer to Thr285 of monozinc MCR-1. PEA is represented 
as dimethyl phosphate (see Methods). Blue dashed lines represent bonds forming; red, bonds breaking. Asterisks (*) mark C atoms. 
 
prevented complete dissociation of the second zinc equivalent, 
but coordination by both His395 and His478 is lost and the Zn2 
ion is instead exclusively bound by two phosphate oxygen 
atoms in bidentate coordination. 
 Histidines 395 and 478 in MCR-1/-2 are both highly 
conserved and functionally important, as adjudged by increased 
colistin susceptibility when either is mutated.7 Aside from their 
possible Zn2 coordination, these residues could participate in 
catalysis, for example stabilising/orienting incoming PEA and/or 
lipid A substrates via interactions with phosphate oxygen 
atoms. However, the requirements for these roles differ in that 
metal coordination would require deprotonation of His N2 
atoms, whereas interaction with substrate phosphate would 
require their protonation. Accordingly, simulations were carried 
out on monozinc, dephosphorylated MCR-1 with His395 and 
His478 both neutral (i.e. singly protonated at N) and 
protonated (at both N and N) to assess the effect of 
protonation upon MCR active site structure and dynamics. 
These identify His478 as adopting a stable conformation 
independent of protonation at N, while protonation affects the 
conformational distribution of His395, which then favours a 
rotamer distinct from the crystal structures (Figures S9, S10). 
 The lability of the MCR Zn2 site supports the feasibility of 
mechanistic hypotheses that require a single zinc ion only. The 
initial step in MCR-catalysed lipid A modification involves PEA 
transfer from the membrane-embedded donor 
(phosphatidylethanolamine) to Thr285, likely via nucleophilic 
attack of Thr285 on the substrate phosphorous centre. In our 
previous report8 we presented preliminary density functional 
theory (DFT) calculations designed to investigate the feasibility 
of PEA transfer by mono- and dizinc MCR-1. We now extend 
these experiments to a higher level of theory in order to obtain 
more realistic energy barriers and test mechanisms involving 
(previously omitted) His395 and His478. Models of the MCR-1 
active site were used as starting points for DFT calculations to 
identify energetically feasible routes for PEA addition to Thr285. 
 Two candidate paths (A and B) for the reaction catalysed by 
monozinc MCR-1 were identified using the B3LYP functional 
with Grimme’s dispersion correction and a combination of 
different basis sets. Reactants, transition states and products 
were identified (RS, TS and PS, respectively, Figures 3, S11), and 
their nature confirmed with frequency calculations. One of 
these pathways (B) consists of a single step where phosphate 
cleavage takes place simultaneously with proton transfer from 
Thr285 to the leaving group (dephosphorylated membrane 
lipid), shuttled by the transient phosphoryl group (TSB, Figure 
S11). In this model all histidine residues remain neutral with 
only one imidazole N atom (either N or N) protonated. This 
pathway resembles some Mg2+-dependent “substrate-assisted” 
kinase mechanisms.18, 19 However, the DFT-calculated barrier 
(41.2 kcal/mol, Figure S12, Table S4) is rather high for this to be 
feasible, and shuttling by the phosphoryl group of a proton from 
Thr285 to the departing lipid would appear unfavourable. 
 If His395 is protonated, a suitable alternative reaction 
pathway (A), resembling previous proposals for phosphonate 
monoester hydrolase17 or “base-assisted” kinase 
mechanisms,18, 19 is found, with phosphate cleavage concerted 
with two proton transfers, from Thr285 to the Glu246 
carboxylate, and from His395 to the dephosphorylated lipidic 
leaving group (Figure 3). The same path is obtained if His395 
and His478 are both protonated (note that His466 coordinates 
Zn1 and cannot be protonated) with a free energy reaction 
barrier height of 10.2 kcal/mol (compared with 20.3 kcal/mol 
when only His395 is protonated) and a free energy of reaction 
of -11.5 kcal/mol (Figures 3, S12; Table S4). Reaction pathways 
A (with His395 and His478 neutral to permit zinc coordination) 
and B were also investigated using dizinc models based on the 
MCR-1 crystal structure (5LRM). In all cases the resulting 
energies were similarly unfavourable, with the lowest reaction 
barrier obtained unfeasibly high at 33 kcal/mol (Table S4). 
Single-point calculations identified only small variations in 
barrier height with dielectric constant (Table S5), confirming the 
size of the cluster model to be appropriate. These new DFT 
calculations thus support the contention that the first step of 
the MCR reaction is energetically feasible with only one Zn2+ ion, 
and moreover imply that PEA transfer to MCR Thr285 occurs by 
a concerted, rather than stepwise process. This mechanism 
likely requires protonation of at least His395, with a further 
reduction in barrier when His478 is also protonated. Our 
findings also accord with recent theoretical studies of 
phosphate ester hydrolysis23 that identify “substrate-assisted” 
mechanisms as disfavoured for all but poor leaving groups. 
 Despite the wide distribution and clinical significance of 
MCR enzymes, the mechanism of PEA transfer remains poorly 
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understood, and is complicated by structural evidence for 
multiple metallated states. Our data demonstrate the MCR 
periplasmic catalytic domain to be a discrete structural entity 
that stably binds a single Zn2+ ion, as evidenced by rapid 
dissociation of a second Zn2+ equivalent during MD simulations. 
DFT calculations, as used to model a range of zinc 
metalloenzyme systems, including alkaline phosphatase (AP)24, 
identify monometallic MCR-1 as supporting PEA transfer to 
Thr285 (the first step of lipid A modification) in a concerted 
mechanism involving Glu246 and His395 in proton transfer 
steps. Glu246 then adopts monodentate Zn1 coordination, as 
seen in MD simulations and crystal structures7, and favoured by 
DFT models. Interaction of the unbound oxygen of MCR-1 
Glu246 with Asn329 is reminiscent of interaction of Asp12 with 
Tyr105 in phosphonate monoester hydrolase17 and Asp54 with 
Tyr205 in nucleotide pyrophosphatase/phosphodiesterase25, 
respectively mono- and bimetallic enzymes that, like MCR, 
hydrolyse phosphate diester substrates. In AP, which favours 
phosphate monoesters25, Asp51 (equivalent to MCR-1 Glu246) 
instead coordinates a Mg2+ ion absent from MCR-1 (Figure S13). 
Our proposed mechanism is then consistent with comparison of 
MCR with AP superfamily members with similar activities. 
 In summary, our data suggest a mechanism for PEA transfer 
to MCR Thr285 that explains the essentiality of His395 in the 
absence of a second zinc ion, distinguishes bacterial PEA 
transferases from multinuclear alkaline phosphatase, and is 
instead more reminiscent of those proposed for monometallic 
members of the wider AP superfamily. Scaffolds with zinc-
binding functionality able to hydrogen bond to charged His395 
then warrant evaluation as candidate inhibitors of this 
important antibiotic resistance mechanism. 
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